JANE STREET GROUP, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,502,113
-11.7%
549,915
+36.7%
0.00%0.0%
Q2 2023$2,832,311
+605.7%
402,317
+512.5%
0.00%
Q1 2023$401,330
-38.4%
65,684
-35.6%
0.00%
Q4 2022$651,262
+11.7%
101,919
+67.6%
0.00%
Q3 2022$583,000
-59.4%
60,818
-53.3%
0.00%
-100.0%
Q2 2022$1,436,000
-85.1%
130,117
-77.5%
0.00%
-66.7%
Q1 2022$9,622,000
+40.2%
577,920
+60.7%
0.00%
+50.0%
Q4 2021$6,865,000
-12.5%
359,617
+13.1%
0.00%
-33.3%
Q3 2021$7,843,000
-46.9%
318,034
-43.9%
0.00%
-50.0%
Q2 2021$14,758,000
+182.8%
567,196
+244.2%
0.01%
+100.0%
Q1 2021$5,218,000
-62.3%
164,787
-44.8%
0.00%
-57.1%
Q4 2020$13,844,000
+42.1%
298,337
+0.8%
0.01%
+40.0%
Q3 2020$9,742,000
-40.6%
295,908
-50.4%
0.01%
-58.3%
Q2 2020$16,390,000
+189.4%
597,098
+215.6%
0.01%
+100.0%
Q1 2020$5,664,000
+599.3%
189,213
+546.8%
0.01%
+500.0%
Q4 2019$810,000
+35.0%
29,255
-11.3%
0.00%0.0%
Q3 2019$600,000
-42.7%
32,982
-22.8%
0.00%
-50.0%
Q2 2019$1,048,000
+539.0%
42,724
+101.5%
0.00%
+100.0%
Q3 2017$164,00021,2040.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,944,201$27,999,00013.31%
Broadfin Capital, LLC 4,328,303$41,162,0008.50%
GREAT POINT PARTNERS LLC 5,567,348$52,945,0005.24%
FRAZIER MANAGEMENT LLC 2,188,331$20,811,0005.01%
Avoro Capital Advisors LLC 10,530,862$100,148,0004.33%
Prosight Management, LP 917,080$8,721,0003.82%
Perceptive Advisors 12,235,811$116,362,0003.28%
Ghost Tree Capital, LLC 1,150,000$10,937,0002.86%
QVT Financial LP 1,021,361$9,241,0002.32%
Cheyne Capital Management (UK) LLP 186,500$1,774,0001.66%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders